Startup de cannabis desarrolla en México línea focada a la salud feminina

Bloomberg — Mennlay Golokeh Aggrey has witnessed How marijuana went from being a main objective of the war against drugs to the favorite focus of venture capital companies.

When she started a small cultivation operation in the prosperous Twin Peaks neighborhood of San Francisco, two decades ago, a neighbor obliged her to close it.

“Personally, I don’t come from a place where there would be someone who would rescue me if they ran over me,” said Aggrey, who was born in the United States to fathers who had immigrated from Western Africa.

Aggrey lives today in Ciudad de México, where he is with the cannabis researcher and defender Karina Primelles. He directs Xula, which uses cannabinoids to manufacture products that address a range of health problems.

This year, the company launched in EE.UU. A line based on CBD called Solo Hemp, to satisfy a variety of needs that include Relaxation, alivio del dolor y salud intestinal.

Su enfoque en las necessidades de las mujeres makes it stand out. One of their products, llamado Happy Period, focuses on cramps, dolores de espalda and digestive problems with 500 milligrams of CBD. Another, llamado Happy Hormones, reinforces the mood with a stronger dose.

Our products are centered on people with wombsAggrey said. “People with uterus, people who have cramps, people who go through hormonal imbalances, people who go through menopause”.

Los cuerpos de las mujeres, aggregate, pasan por “estas molestias y por todos estos hermosos ciclos” que el mercado del cannabis rara vez aborda, lo que convertivo a las mujeres en un mercado “extremadamente neglected”.

Una encuesta de 2019 estima que casi 900,000 women in the United Kingdom quit their jobs due to menopause symptoms. It is probable that women of this age group are encountering a key point in their careers.

It is more likely that they are eligible for senior management positions, and losing this opportunity contributes to the gender gap. También es malo para las empresas; a nivel mundial, The loss of productivity related to menopause can rise to more than US$150,000 million per yearaccording to Reenita Das, socia y vicepresidente senior de salud y ciencias biológicas de la consultora Frost & Sullivan.

As part of a new, strongly regulated industry, companies that sell products derived from cannabis, whether they use CBD, the lesser-known cannabigerol (CBG) or cannabinol (CBN), face a series of challenges.

En EE.UU., la compañía pisa una línea muy fina trying to inform the consumer about the content of his products without medical attributions.

“Dado que no somos pharmaceutical products and no somos un suplemento, We are in a strange gray area where we cannot put the word ‘menopause’ on the product page or in the box or in any other material.‘, says Aggrey. “Es una palabra medica, por lo que conlleva una attribution medica.” No podemos decir specificifica ‘calambres menstruales'”.

De ahí los nombres divertidos de Xula para sus products, como Moon-a-pause (an equivalent divertido en español could be “Lunapausia”), Calm+clarity (calma y claridad), y Lights out (apagar las luces), una ayuda para dormir

The company publishes blog entries and an index on its web site, where you can read about the benefits of cannabinoids and herbs that you use. All Xula products have been tested by a third party to provide consumers with a verified list of the herbs they contain.

Many startups have started promoting CBD as a healthy, restorative and plant-based ingredient. Depending on the marketing materials you read, it can provide relief for almost all diseases known to the modern human being: anxiety, chronic back pain, muscular pain, dandruff and even sore lips.

Pero algunas iniciales iniciales destillan optimism de que la ciencia podría recendar los testimonios. In August, the Australian organization of mental health juvenile Orygen discovered that the adolescents and young adults with treatment-resistant anxiety who received a single daily pill of CBD during 12 weeks reported that their symptoms were reduced by an average of 43%.

A research by the FN media group predicts that the global CBD oil market will register a compound annual growth rate of 38.9% from 2021 to 2029, from US$9,860 million to US$136,640 million.

Aggrey began his career in the county of Humboldt, California, la “terra prometida de la marihuana”, como ella la llama. After graduating from the university in 2005, he started working on the World of Possibilities radio program. It didn’t take much time before he left his post and followed his passion as the “OG marijuana leader”.

Rápidamente se dio cuenta. “Algunas mujeres que conocí me acogieron bajo su ala y me mostraron cómo eran las cosas”, he says. “Y ese fue mi curso intensivo en agricultura”. Under the Proposition 215 that was approved in 1996, began his operation of cultivation interior professional, legal y con licencia completa en San Francisco.

In 2014 he moved to Mexico City. México estaba entonces considering cambios en su política de marihuana. In 2015, the Supreme Court of the country fell in favor of recreational use, which provoked a prolonged debate about legalization and regulation.

In 2018, he met Primelles through a friend. “We had no idea that the industry would open here in Mexico“, dice. “Fue cuando eso sucedió that Karina and I started research and development”. Xula started selling its products in the EU. in October 2020.

They can cultivate and legally sell their botanical products and organic hemp in EE.UU., thanks to the Farm Bill of 2018.

As such, says Aggrey, “we cannot advertise so freely what the product permits as other supplements, a saber el aceite de pescado or el ginkgo”.

Aggrey y Primelles son conscientes de su peculiar estatus en la naciente industria. Son mujeres de color que poseen y dirigen una empresa que vende muy antiguos remedios después de decades of demonization and massive incarceration of Latinos and Negroes.

“I feel that the popular creedia de la población negra, latina e indígena conforma la cultura del cannabis y es quezás la base de la cultura, pero hay acceso para nosotros. Es caro”, said Aggrey. “E incluso como consumidor, no nos llega el mercadeo. Uno no le importa a nadie si es de raza negra y mayor de 40 años. Ahí ya nos dicen ‘adiós'”.

Eventually, Xula wants to sell products that contain marijuana. Son populares, confiables y, según Aggrey, más efectivos.

Honestamente, mi cofundadora y yo solo queremos vender THC. Queremos vender hierba“, said Aggrey. “Queremos hacerlo legalme porque sabemos que es el cannabinoide más potente; y cuando está presente, even with others like CBG and CBN, it simply works better”.

Read more on Bloomberg.com

Leave a Reply

Your email address will not be published.

Back to top button
DRAGONINKHOUSE